| How should public policy respond to the challenges of modern biotechnology? | |
| | |
MedLine Citation:
|
PMID: 15193337 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Modern biotechnology has been a topic of public and political debate around the world for over 30 years; continuing scientific breakthroughs keep it high on the agenda. Policy responses have been diverse, fragmented and incoherent, at levels ranging from local regions to agencies of the United Nations, but particularly in national administrations and the European Union. Reactions have been ambivalent, combining fears about conjectural risks with concern to maintain competitiveness and exploit beneficial applications. Adverse public perceptions have become a significant influence on policy, in combination with more cynical and self-interested motives of some of the players in policy debates. Future options, in Europe and elsewhere, are constrained by past and continuing mistakes and over-reactions. |
| | |
Authors:
|
Mark Cantley |
Related Documents
:
|
20517317 - European micronutrient recommendations aligned: a general framework developed by eurreca. 19819897 - An exploration of the theoretical concepts policy windows and policy entrepreneurs at t... 20054077 - A public-policy practicum to address current issues in human, animal, and ecosystem hea... 15214607 - Developments in national physical activity policy: an international review and recommen... 3540657 - Effects of chemical combinations on the induction of aneuploidy in saccharomyces cerevi... 8460417 - Transhiatal esophagectomy using a ring dissector. |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Current opinion in biotechnology Volume: 15 ISSN: 0958-1669 ISO Abbreviation: Curr. Opin. Biotechnol. Publication Date: 2004 Jun |
Date Detail:
|
Created Date: 2004-06-14 Completed Date: 2005-01-12 Revised Date: 2005-11-16 |
Medline Journal Info:
|
Nlm Unique ID: 9100492 Medline TA: Curr Opin Biotechnol Country: England |
Other Details:
|
Languages: eng Pagination: 258-63 Citation Subset: IM |
Affiliation:
|
European Commission (SDM-8/19), B-1049 Brussels, Belgium. mark.cantley@cec.eu.int |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Biotechnology
/
methods*,
trends* Dissent and Disputes Europe International Cooperation Perception Public Opinion Public Policy* Safety |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Biotechnology--a challenge to the patent system.
Next Document: Facing the possibility of bioterrorism.